Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- These Are The People Who Will Be Soaked In Cash After Twitter's IPO also written by Reuters
- New Walgreens CEO to Get Nearly $25 Million Signing Bonus also published in Chicago Tribune
- UBS Still Needs to Get Rid of Investment Bank - Activist Investor also written by Reuters
- Vivendi Employees Back Bollore Against Activist Challenge also written by Reuters
- Lululemon Has A New CEO also written by Reuters
- Exclusive: IBM hired advisers to deal with restless investors - sources also written by Reuters
- A Changed and Changing Executive Compensation Environment also mentions Disclosures on Compensation
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
Login to comment.